[Chemotherapy in the treatment of the early relapse of cervical cancer].
OBJECTIVE
The treatment with chemotherapy in early recidivations or high clinical stages of the carcinoma of the cervix was analysed.


METHODS
17 cases early recidivation or high clinical stages in different histopathological types and clinical stages of the cervix cancer were treated with polychemotherapy (5-FU, Adriamycin, Vincrystin and Cyclophosphamide) and monochemotherapy with Carboplatin. The tolerance of these two chemotherapy programs was assessed.


RESULTS
The same effectiveness of these two programs was observed, but the side effects after Carboplatin treatment were better tolerated then after polychemotherapy program.


CONCLUSIONS
Carboplatin is the drug of choice in the treatment of the early recidivations of the cervix cancer.
I Katedry i Kliniki Ginekologii AM we Wrocławiu.
A
A
Popiela
M
M
Mazurec
A
A
Karmowski
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D018283:Cystadenocarcinoma, Papillary / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D014594:Uterine Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents